CD44 and neoplasm: Next, to examine if IL-6 affects stem cell compartment in gastric tumorigenesis, we performed immunohistochemical analysis of CD44, which has been proposed to be a stem cell marker in gastric tumorigenesis [31], in non-tumor part of stomach obtained from WT and IL-6−/− mice 40 weeks after starting MNU administration.